PhaseRx(Seattle, WA) an early-stage siRNA therapeutic company closed a $19M Series A financing. Participants include 5AM Ventures, Arch Venture Partners and Versant Ventures.
Fatal error: Call to undefined function php() in /home/onbiovcc/public_html/wp-content/themes/bx-blue-green/single.php on line 25
